Carcinogenicity of human papillomavirus (HPV) types in HIV-positive women: a meta-analysis from HPV infection to cervical cancer

GM Clifford, S Tully, S Franceschi - Clinical Infectious Diseases, 2017 - academic.oup.com
Background. Data on the relative carcinogenic potential of human papillomavirus (HPV)
types among women infected with human immunodeficiency virus (HIV)(WHIV) are needed …

[HTML][HTML] HPV16 E7 genetic conservation is critical to carcinogenesis

L Mirabello, M Yeager, K Yu, GM Clifford, Y Xiao, B Zhu… - Cell, 2017 - cell.com
Although most cervical human papillomavirus type 16 (HPV16) infections become
undetectable within 1–2 years, persistent HPV16 causes half of all cervical cancers. We …

Effectiveness of high-risk human papillomavirus testing for cervical cancer screening in China: a multicenter, open-label, randomized clinical trial

J Zhang, Y Zhao, Y Dai, L Dang, L Ma, C Yang… - JAMA …, 2021 - jamanetwork.com
Importance Evidence is needed regarding the introduction of high-risk human
papillomavirus (hrHPV) testing into China's national cervical cancer screening program …

Role of HPV genotype, multiple infections, and viral load on the risk of high-grade cervical neoplasia

R Adcock, J Cuzick, WC Hunt, RM McDonald… - … Biomarkers & Prevention, 2019 - AACR
Background: Human papillomavirus (HPV) testing provides a much more sensitive method
of detection for high-grade lesions than cytology, but specificity is low. Here, we explore the …

Cumulative risk of cervical intraepithelial neoplasia for women with normal cytology but positive for human papillomavirus: systematic review and meta‐analysis

T Malagon, KD Volesky, S Bouten… - … Journal of Cancer, 2020 - Wiley Online Library
Most women positive for human papillomavirus (HPV) are cytology normal. The optimal
screen‐management of these women is unclear given their risk of developing precancer …

Approaches to triage optimization in HPV primary screening: extended genotyping and p16/Ki‐67 dual‐stained cytology—retrospective insights from ATHENA

MH Stoler, E Baker, S Boyle, S Aslam… - … Journal of Cancer, 2020 - Wiley Online Library
The objective of our study was to assess the performance of different triage strategies for
high‐risk human papillomavirus (hrHPV)‐positive results utilizing either extended …

Prevalence of human papillomavirus infection among Iranian women using COBAS HPV DNA testing

F Jamdar, F Farzaneh, F Navidpour, S Younesi… - Infectious agents and …, 2018 - Springer
Abstract Background Persistent infection with High Risk Human Papillomavirus (HR HPV)
types plays a major role in the development of cervical cancer. Therefore, the detection of …

Comparison of HPV-16 and HPV-18 genotyping and cytological testing as triage testing within human papillomavirus–based screening in Mexico

L Torres-Ibarra, J Cuzick, AT Lorincz… - JAMA network …, 2019 - jamanetwork.com
Importance Triage tests enhance the efficiency cervical cancer screening based on human
papillomavirus (HPV), but the best approach for maximizing programmatic effectiveness is …

[HTML][HTML] The impact of alternate HPV vaccination and cervical screening strategies in Japan: a cost-effectiveness analysis

MR Palmer, E Saito, K Katanoda… - The Lancet Regional …, 2024 - thelancet.com
Summary Background The Japanese 2020 cervical screening guidelines recommend
conventional cervical cytology screening every 2-years for women aged 20–69 years. The …

Cervical precancers and cancers attributed to HPV types by race and ethnicity: implications for vaccination, screening, and management

J Mix, M Saraiya, BD Hallowell, B Befano… - JNCI: Journal of the …, 2022 - academic.oup.com
Background Racial and ethnic variations in attribution of cervical precancer and cancer to
human papillomavirus (HPV) types may result in different HPV vaccine protection, screening …